SEC Form 4 · accession 0001127602-17-018621
FMC CORP · FMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Norris
Officer — President Health Nutrition
Period of report
May 16, 2017
Accepted (ET)
May 18, 2017 · 3:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000037785
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 16, 2017 | M | 2,642 | $40.885 | A | 28,750 | D | |
| Common Stock | May 16, 2017 | M | 2,484 | $47.595 | A | 31,234 | D | |
| Common Stock | May 16, 2017 | M | 3,444 | $59.47 | A | 34,678 | D | |
| Common StockF1 | May 16, 2017 | S | 2,642 | $75.961 | D | 32,036 | D | |
| Common StockF2 | May 16, 2017 | S | 2,484 | $75.953 | D | 29,552 | D | |
| Common Stock | May 16, 2017 | S | 3,444 | $75.958 | D | 26,108 | D | |
| Common StockF3 | May 16, 2017 | S | 1,494 | $75.839 | D | 24,614 | D | |
| Common Stock | May 17, 2017 | S | 1,294 | $74.25 | D | 23,320 | D | |
| Common StockF4 | holding | — | — | — | 6,288 | I | Thrift Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $40.89 | May 16, 2017 | M | 2,642 | D | Feb 17, 2014 | Feb 17, 2021 | Common Stock | 2,642 | 0 | D |
| Stock Option (Right to Buy) | $47.60 | May 16, 2017 | M | 2,484 | D | Feb 16, 2015 | Feb 16, 2022 | Common Stock | 2,484 | 0 | D |
| Stock Option (Right to Buy) | $59.47 | May 16, 2017 | M | 3,444 | D | Feb 18, 2016 | Feb 18, 2023 | Common Stock | 3,444 | 0 | D |
Explanation of responses
- F1Represents the weighted average sales price for price increments ranging from $75.951 to $75.968. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- F2Represents the weighted average sales price for price increments ranging from $75.950 to $75.960. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- F3Represents the weighted average sales price for price increments ranging from $75.826 to $75.871. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- F4Based on plan statement as of May 16, 2017.